Follow-The-Filings

ASBP Aspire Biopharma

Aspire Biopharma earnings company data as of 4:49 AM ET 10/4

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

2 periods · newest first · EPS & Rev stacked · nothing reported yet

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 4.01,9.01
8-K 5.03,8.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
10-Q
8-K 1.01,2.03,3.02,7.01,9.01
8-K 8.01
8-K 5.07
8-K 1.01,7.01,9.01
8-K 8.01
10-Q
8-K 5.03,9.01
8-K 7.01,9.01
8-K/A 1.01,5.03,9.01
8-K 7.01,9.01
8-K 5.07
8-K 1.01,5.03,9.01
8-K 1.01
S-1/A
10-K/A
10-K
S-1
8-K 1.01,3.02,5.02,7.01,9.01
8-K 5.03,9.01
8-K 1.01,3.02,9.01

Consensus estimates · SEC filings remain the official record · not investment advice